BRNS Barinthus Biotherapeutics PLC Yalpi foyda normasi

Barinthus Biotherapeutics PLC (BRNS) korporativ emblemasi va logotipi

Barinthus Biotherapeutics AI algoritmlari va robototexnika yordamida T-hujayra patologiyalari uchun dori vositalarini kashf etishni avtomatlashtiradi. Ular ishlab chiqayotgan VTP ekotizimi saraton va gepatitga qarshi kurashish uchun immunitetni faollashtiradi. Valo profit marjasi ushbu jarayonlarning samaradorligini ko'rsatadi va ushbu ko'rsatkich 0.00 darajasida turibdi. Biotexnologiyalarga bo'lgan barqaror talab kompaniyani makroiqtisodiy inqirozlardan himoya qiladi va aktivni defensiv aktivga aylantiradi.

BRNS Barinthus Biotherapeutics PLC Yalpi rentabellik (21.02.2024 - 19.09.2026)

Barinthus Biotherapeutics (BRNS) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Barinthus Biotherapeutics
Barinthus Biotherapeutics Corp yetakchi tovari

Innovatsion T-hujayra vaksinalarini ishlab chiquvchi Barinthus Biotherapeutics (BRNS) uchun yalpi foyda marjasi bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin uning noyob viral vektorlarining monetizatsiya samaradorligini aks ettiradi. Yalpi daromad ko'rsatkichi tahlili operatsion xarajatlarni qoplash uchun qolgan foyda ulushini baholash imkonini beradi, bu esa kompaniyaning kapitalizatsiyasining fundamental barqarorligini va uning yuqori texnologik aktivlarining sifatini belgilaydi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik enGene Holdings Inc.|RAPT: Yalpi foyda normasi|Yalpi marja JBIO|Yalpi foyda bo'yicha rentabellik aclaristx.com ACRS|Yalpi rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Yalpi foyda marjasi|Cabaletta Bio, Inc - Yalpi marja|Yalpi foyda marjasi Ventyx Biosciences|THTX (theratech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Yalpi marja|Yalpi foyda marjasi Agenus Inc. AGEN|Yalpi foyda bo'yicha rentabellik CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Yalpi foyda normasi|Yalpi rentabellik atyrpharma.com ATYR|Yalpi marja Adagene Corp ADAG|IMA - Yalpi rentabellik|Yalpi foyda normasi STTK (Shattuck Labs)|EQ: Yalpi marja|Connect Biopharma (CNTB) - Yalpi marja|Yalpi rentabellik Immunic|Yalpi marja atarabio.com|Yalpi marja IFRX|Yalpi marja X4 Pharma (XFOR)|Yalpi marja ACET (adicetbio.com)|Yalpi marja Celularity Inc. CELU|INMB - Yalpi rentabellik|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik